regadenoson has been researched along with atropine in 6 studies
| Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) |
|---|---|---|---|---|---|
| 321 | 53 | 264 | 26,711 | 1,259 | 1,697 |
| Protein | Taxonomy | regadenoson (IC50) | atropine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 21.41 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.012 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0067 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0007 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0009 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0015 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0021 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.354 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alam, M; Ananthasubramaniam, K; Boedeker, S; Brooks, K; Iyer, H; Khandelwal, A; Nguyen, P; Saad, H; Shaikh, K; Wang, DD | 1 |
| Latus, KA; Reyes, E; Standbridge, K; Underwood, SR; Walker, S; Wechalekar, K | 1 |
| Agarwal, V; DePuey, EG | 1 |
| Hage, FG; Iskandrian, AE | 1 |
| Carafa, MRP; Flammia, FC; Larici, AR; Lo Piccolo, F; Marano, R; Meduri, A; Merlino, B; Natale, L; Rovere, G; Savino, G | 1 |
2 review(s) available for regadenoson and atropine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Practical instructions for using drugs in CT and MR cardiac imaging.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Anxiety Agents; Atropine; Calcium Channel Blockers; Cardiac Imaging Techniques; Computed Tomography Angiography; Contraindications, Drug; Coronary Angiography; Coronary Vessels; Dipyridamole; Dobutamine; Heart; Humans; Ivabradine; Magnetic Resonance Imaging; Nitroglycerin; Purines; Pyrazoles; Vasodilator Agents | 2021 |
4 other study(ies) available for regadenoson and atropine
| Article | Year |
|---|---|
Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.
Topics: Adenosine A2 Receptor Agonists; Anti-Arrhythmia Agents; Atropine; Coronary Angiography; Coronary Artery Disease; Dyspnea; Echocardiography, Stress; Feasibility Studies; Female; Headache; Humans; Male; Middle Aged; Patient Satisfaction; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires | 2014 |
Regadenoson-induced bradycardia and hypotension: possible mechanism and antidote.
Topics: Adenosine A2 Receptor Agonists; Antidotes; Atropine; Bradycardia; Exercise Test; Humans; Hypotension; Purines; Pyrazoles; Vasodilator Agents | 2014 |
Regadenoson and seizures: a real clinical concern.
Topics: Atropine; Bradycardia; Exercise Test; Humans; Hypotension; Purines; Pyrazoles | 2014 |
Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.
Topics: Adenosine A2 Receptor Agonists; Atropine; Bradycardia; Coronary Artery Disease; Exercise Test; Female; Heart Arrest; Humans; Hypotension; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents | 2014 |